|
|
|
|
|
Single-Use Applications for Biopharmaceutical Manufacturing
2011年6月6-8日 、 Sheraton Boston Hotel 、 Boston, MA
单次使用技术在生物医药品制造领域迅速一般化。该技术造成减少成本的效果及具备相当出色的柔软性、以及转换方向快速,已经不容置疑。然随著制药业界单次使用技术的普及,亦浮现许多疑点。
以高水准重点会议及有出色的科学谘询委员会而广为人所知的此学会,每次都提出刺激的问题及独创性的解决方法,拨动参加者对知识的好奇心,此次会议亦深受瞩目。
FDA's Perspectives and Guidance on Single-Use
Anastasia G. Lolas, M.S.
Microbiologist, Biotech Manufacturing Team/MAPCB/DMPQ, Office of Compliance
CDER, FDA (invited)
Bravely Deploying Single-Use Technologies at Commercial Scale: How Project Atlas Leveraged Single-Use Technology to Achieve Lower Cost, More Flexible Manufacturing
William (Bill) Ciambrone
Senior Vice President Technical Operations
Shire Human Genetic Therapies
Multi-Purpose Facility Use, Multi-Product Facility Manufacturing, Vaccines and Biotherapeutics
Kent Murphy, Ph.D.
Senior Director, Operations Management
Pfizer, Inc.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group 中文官方网站营运 : IBC Life Sciences 代理商 日商环球讯息有限公司
Powered by Interactive Agency Janmedia Interactive, Inc.